EcoDrugPlus

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSUPAG00010013615
Gene Symbol: CSF1R
1 Cross references
206 Possible Orthologues:

Complement C1s

Ensembl ID : ENSUPAG00010011857
Gene Symbol: C1S
3 Cross references
199 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSUPAG00010000558
Gene Symbol: CRHR1
3 Cross references
240 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSUPAG00010007111
Gene Symbol: CCND1
1 Cross references
277 Possible Orthologues:

Cyclin Dependent Kinase 1

Ensembl ID : ENSUPAG00010014842
Gene Symbol: CDK1
1 Cross references
227 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSUPAG00010015183
Gene Symbol: CDK2
3 Cross references
202 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSUPAG00010006800
Gene Symbol: CDK5
1 Cross references
169 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSUPAG00010014338
Gene Symbol: CDK6
1 Cross references
198 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSUPAG00010021083
Gene Symbol: CDK7
3 Cross references
213 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSUPAG00010014391
Gene Symbol: CDK9
3 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSUPAG00010007962
Gene Symbol: CYSLTR1
1 Cross references
177 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSUPAG00010016243
Gene Symbol: CDA
3 Cross references
224 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).